by
Vincent Mor, PhD
Seminar date: 4/18/2018
Description: The VHA does not require Veterans receiving hospice care, regardless of which agency provides it, to forgo disease altering therapeutic interventions like chemotherapy and radiation therapy. We take advantage of the decade long investment VHA made in hospice and palliative care services to estimate the impact of this policy on outcomes experienced by newly diagnosed Stage IV non-small cell lung cancer patients. We find the concurrent care option does not increase costs and reduces the likelihood of Veterans experiencing burdensome transitions. Target Audience: Investigators and clinicians working with patients with advanced disease.
DOWNLOAD: PDF handout | Audio only (mp3) | transcript
